Scientific and Ethics Advisory Board Members

Professor Bryan Williams is Chair of Medicine at University College London (UCL) and currently serves as the Chair of the International Society of Hypertension (ISH). He is a globally recognized expert in hypertension and cardiovascular medicine, known for his leadership in developing international clinical guidelines and for his contributions to translational research in vascular pathophysiology. Professor Williams has authored numerous high-impact publications and has played a pivotal role in shaping modern hypertension management worldwide. His work bridges clinical excellence, academic leadership, and global advocacy for cardiovascular health.

Professor Giuseppe Mancia is a world-renowned expert in cardiovascular medicine and a leading authority in the field of hypertension. He is Professor Emeritus of Medicine at the University of Milano-Bicocca and President of the European Society of Hypertension (ESH) Foundation and former President of ESH and the International Society of Hypertension (ISH). Professor Mancia has made seminal contributions to the understanding and management of hypertension, particularly in the areas of ambulatory blood pressure monitoring, sympathetic nervous system activation, cardiovascular risk stratification and real life population studies on adherence to treatment. He has served as chair and co-author of numerous European hypertension guidelines and is a highly cited figure in cardiovascular research. His academic work has had a profound impact on both clinical practice and health policy across Europe and beyond.

Professor Olivia Wu is a globally recognised expert in health technology assessment (HTA). She holds the William R Lindsay Chair at the University of Glasgow, as well as Adjunct Professor at Mahidol University in Thailand. Her research spans a wide range of health interventions, with including the evaluation of digital health applications, including the accounting for ethical and data protection challenges involved in collecting patient data via digital tools. She has led numerous economic evaluations alongside clinical trials, informing clinical guidelines and health policy nationally and internationally. Professor Wu has recently been appointed Director of the UK NIHR  Better Methods Better Research and of the National Research Collaboration Programmes. She continues to advises HTA agencies worldwide, and co-leads the Women in Health Economics and Outcomes Research Initiative at ISPOR, mentoring researchers globally.